CN1183290A - Anticancer drug - Google Patents
Anticancer drug Download PDFInfo
- Publication number
- CN1183290A CN1183290A CN96119582A CN96119582A CN1183290A CN 1183290 A CN1183290 A CN 1183290A CN 96119582 A CN96119582 A CN 96119582A CN 96119582 A CN96119582 A CN 96119582A CN 1183290 A CN1183290 A CN 1183290A
- Authority
- CN
- China
- Prior art keywords
- parts
- accessory drugs
- main formula
- weight
- formula agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine in the form of powder for curing cancer is prepared from 9 Chinese-medicinal materials such as oldenlandia, subprostrate sophora root, barbat skullcap, batryticated silkworm, honeysuckle flower, etc. through crushing to 60-80 meshes, and features no by-effect.
Description
The present invention relates to Chinese herbal medicine, specifically a kind of have prevention, treatment, anticancer to shift and adsorb the medicine of carcinomycin effect to cancer.
At present, be first-selected therapeutic scheme normally for treatment for cancer with operation, in the time of postoperative chemotherapy and radiotherapy, cooperate the medicine of oral raising immunocompetence.This kind therapeutic scheme, operation can make the patient suffering, radiation and chemotherapy can kill and wound leukocyte and reduce intravital immunocompetence, in, patient with advanced cancer, operation or chemotherapy all are difficult to reach ideal effect, and side effect is serious.In case of not taking the patient of operative treatment and radiation and chemotherapy, just felt simply helpless.
The objective of the invention is shortcoming at above-mentioned existence, provide a kind of need operation and radiotherapy, chemotherapy, therapeutic effect is better, the oral Chinese herb medicine that side effect is little.
Preparation of the present invention comprises main formula agent and accessory drugs, and the formation of main formula agent (by weight) is:
5～15 parts of 5～20 parts of Radix Sophorae Tonkinensiss of Hedyotidis Diffusae
5～10 parts of 5～20 parts of Periostracum Cicadae of Herba Scutellariae Barbatae
5～10 parts of 5～20 portions of Bombyx Batryticatus of Fructus actinidiae chinensis
5～10 parts of 5～20 parts of Radix Ginsengs of Flos Lonicerae
Accessory drugs (by weight) is: 6～10 parts of chitins
Hedyotidis Diffusae, Herba Scutellariae Barbatae, Fructus actinidiae chinensis, Flos Lonicerae, Radix Sophorae Tonkinensis, Periostracum Cicadae, Bombyx Batryticatus, the Radix Ginseng powder that the main formula agent is contained is broken to 60～80 orders earlier, dress bubble bag; Accessory drugs chitin (chitin, chitosan) is a powder packets.
It is 10～12 grams that bubble bag weight is adorned in the main formula agent, and adjuvant powder packets weight is 2～4 grams.
The medicine that the present invention is given, lymphocyte in the activating human body effectively, the transfer of anticancer, strengthen the immunocompetence and the cellular immune function of human body fluid, take this medicine and do not have the side effect that chemical medicinal treatment brought before, and patient's medication is convenient, and its prescription is reasonable, and preparation method is simple.
Provide embodiment below:
1. get 5 parts of Hedyotidis Diffusaes, 5 parts of Herba Scutellariae Barbataes, 5 parts of Fructus actinidiae chinensis, 5 parts of Flos Loniceraes, 5 parts of Radix Sophorae Tonkinensiss, 5 parts of Periostracum Cicadae, 5 parts of Bombyx Batryticatus, 5 parts of Radix Ginsengs, be crushed to 60 orders and be principal agent by 10 gram amounts dress bubble bag; Chitin is an accessory drugs by 2 gram amounts; Constitute main and auxiliary prescription.
Principal agent is decoction made from powder 10 gram bubble bag drink-services, is advisable to steep to drink after meal; Accessory drugs 2 grams are powder (powder is planar) drink-service separately, every day three times, are advisable during with dining.
2. get 15 parts of Hedyotidis Diffusaes, 15 parts of Herba Scutellariae Barbataes, 15 parts of Fructus actinidiae chinensis, 15 parts of Flos Loniceraes, 15 parts of Radix Sophorae Tonkinensiss, 10 parts of Periostracum Cicadae, 10 parts of Bombyx Batryticatus, 10 parts of Radix Ginsengs by weight, be crushed to 70 orders and constitute accessory drugs by 12 gram amounts dress bubble bag (principal agent) chitin by 3 gram amounts dress bag, instructions of taking is with example 1.
Claims (3)
1. anticancer miraculous cure thing that is used for the treatment of cancer, it is characterized in that: it comprises main formula agent and accessory drugs:
A. the main formula agent is by weight:
5～15 parts of 5～20 parts of Radix Sophorae Tonkinensiss of Hedyotidis Diffusae
5～10 parts of 5～20 parts of Periostracum Cicadae of Herba Scutellariae Barbatae
5～10 parts of 5～20 portions of Bombyx Batryticatus of Fructus actinidiae chinensis
5～10 parts of 5～20 parts of Radix Ginsengs of Flos Lonicerae
B. accessory drugs is: 6～10 parts of chitins.
2. according to the preparation method of the described medicine of claim 1, it is characterized in that Hedyotidis Diffusae, Herba Scutellariae Barbatae, Fructus actinidiae chinensis, Flos Lonicerae, Radix Sophorae Tonkinensis, Periostracum Cicadae, Bombyx Batryticatus, the Radix Ginseng powder that the main formula agent is contained is broken to 60～80 orders earlier, dress bubble bag; The accessory drugs chitin is a powder packets.
3. according to the described medicine of claim 1, it is characterized in that it is 10～12 grams that bubble bag weight is adorned in the main formula agent, accessory drugs powder packets weight is 2～4 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96119582A CN1069205C (en) | 1996-11-26 | 1996-11-26 | Anticancer drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96119582A CN1069205C (en) | 1996-11-26 | 1996-11-26 | Anticancer drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1183290A true CN1183290A (en) | 1998-06-03 |
| CN1069205C CN1069205C (en) | 2001-08-08 |
Family
ID=5125827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96119582A Expired - Fee Related CN1069205C (en) | 1996-11-26 | 1996-11-26 | Anticancer drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1069205C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102652802A (en) * | 2012-04-18 | 2012-09-05 | 南京中医药大学 | Application of cancerous toxin prescription in aspect of preparing medicament for adjusting and controlling signal transduction hepatoma cell TLRs/NF-kB |
| CN106974963A (en) * | 2017-03-24 | 2017-07-25 | 北海市宝珠林海洋科技有限公司 | A kind of anticancer honeyed bolus and preparation method thereof |
| CN110179875A (en) * | 2019-04-13 | 2019-08-30 | 四川代代相传生物科技有限公司 | A kind of Chinese medicine composition of prophylactic treatment liver human primary gastrointestinal cancers |
-
1996
- 1996-11-26 CN CN96119582A patent/CN1069205C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102652802A (en) * | 2012-04-18 | 2012-09-05 | 南京中医药大学 | Application of cancerous toxin prescription in aspect of preparing medicament for adjusting and controlling signal transduction hepatoma cell TLRs/NF-kB |
| CN106974963A (en) * | 2017-03-24 | 2017-07-25 | 北海市宝珠林海洋科技有限公司 | A kind of anticancer honeyed bolus and preparation method thereof |
| CN110179875A (en) * | 2019-04-13 | 2019-08-30 | 四川代代相传生物科技有限公司 | A kind of Chinese medicine composition of prophylactic treatment liver human primary gastrointestinal cancers |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1069205C (en) | 2001-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1164298C (en) | Chinese medicine for treating cold and cough | |
| CN101204559A (en) | Medicaments composite for coronary heart disease, angina and epigastralgia and preparation method thereof | |
| CN102772523B (en) | Bitter glossy ganoderma composition for oncotherapy and preparation method of bitter glossy ganoderma composition | |
| CN1069205C (en) | Anticancer drug | |
| CN1903321A (en) | Traditional Chinese medicine pills for prolonging life and consolidating vital essential | |
| CN1038813C (en) | Traditional Chinese medicine for curing osteoporosis | |
| CN101612347A (en) | Health-care medicinal liquor for treating irregular menstruation | |
| CN1315186A (en) | Medical tea for treating leukoderma and its preparing process | |
| CN102872368A (en) | Chinese medicine acupoint application preparation for purging fire for removing toxin | |
| CN1080565C (en) | Fuyanyu (exterior-use capsule) | |
| CN1141970C (en) | Compound Chinese medicine tea bag for curing fatty liver and hyperlipemia and its production method | |
| CN100364605C (en) | Specific pellet for treating cold, and preparation method | |
| CN1425456A (en) | Nourishing wine for regulating human body balance function | |
| CN1106696A (en) | Chinese herbal medicine hepatitis B recovering agent and its preparing method | |
| CN101129686A (en) | Powder of radix bupleuri and radix Paeoniae alba for treating stomach ache | |
| CN2179164Y (en) | Cathartic curing bag | |
| CN1259373A (en) | Medicinal pill for protecting safety of fetation | |
| CN1990027A (en) | Traditional Chinese medicine for treating bone fracture delayed healing | |
| CN1141109C (en) | Chinese patent medicine for curing acute leukemia and its preparation process | |
| CN1128662A (en) | Oral liquid for curing cancer and prepn. method thereof | |
| CN1589863A (en) | Compound hemorrhoid dispersing powder and its processing method | |
| CN1040724C (en) | Method to prepare speech-restoring pill | |
| CN1254591A (en) | Dual-phase anticancer capsule | |
| CN1070066C (en) | Chinese medicine for cholecystitis | |
| CN1068204C (en) | A Chinese medicinal preparation for treating salpingemphraxis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |